If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

Cipla , India's third-biggest drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday, helped by ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Energy Transfer LPET units appear to be relatively undervalued compared to the Zacks Oil and Gas Production Pipeline – MLB industry. The company's current trailing 12-month Enterprise Value to ...

When President Trump signed an executive order this month to try to reduce drug prices, the pharmaceutical industry scored a big win. Within 90 days, the order said, Trump’s staff should put ...

about the impact geopolitical changes in Europe might have on the bio/pharmaceutical industry. Political shifts in the United Kingdom and Europe may have a negative impact on research efforts for gene ...

Timeline of tariffs for the pharma industry between 26 March and 16 April 2025. Credit: GlobalData. In early 2025, US President Donald Trump mentioned the possibility of potential tariffs on ...

India’s pharmaceutical industry, valued at around $50 billion in 2023, is among the leading suppliers of active pharmaceutical ingredients globally. According to the Pharmaceuticals Export ...

Bayer has overturned a ruling that it brought discredit on the pharma industry. Accused of “warming the market” for a new Eylea indication, the German drugmaker successfully argued on appeal ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...

As its title might imply, the presentation—guided by Doug Long, IQVIA’s vice president of industry relations—explores the current landscape of the US pharmaceutical industry by detailing market ...